Business Standard

Sunday, February 09, 2025 | 04:57 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Parmax Pharma Share Price

Know More
BSENSE

47.76-0.07 (-0.15%)

7-Feb-2025
Stock not traded

BSE : 540359

NSE :

Sector : Health care

ISIN Code : INE240T01014

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 07-Feb-2025

Market Cap (₹ Cr)

18

Traded Value (₹ Cr)

0.00

Volume (Shares)

764

Face Value (₹)

10

52-Week High (₹)

54.00

52-Week High Date

27-Sep-2024

52-Week Low (₹)

24.18

52-Week Low Date

13-Mar-2024

All Time High (₹)

81.90

All Time High Date

18-Jun-2021

All Time Low (₹)

4.25

All Time Low Date

03-Jul-1996

Parmax Pharma Ltd

Incorporated in Nov.'94 Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin Amoxycillin Cephalexin Nalidixic Acid etc. The Company then discontinued their business activities for few years due to various reasons. Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate ampicillin tr...
Read More

Parmax Pharma Announcement

More

Parmax Pharma Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

18

EPS - TTM (₹) [S]

0.00

P/E Ratio (X) [S]

-

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]-2.16
P/B Ratio (₹) [S]-22.11

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

47.76

50.90

Week Low/High (₹)

38.10

51.00

Month Low/High (₹)

36.20

51.00

Year Low/High (₹)

24.18

54.00

All time Low/High (₹)

4.25

82.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week16.49%%0.460.22%
1 Month11.80%%-0.43-0.62%
3 Month1.62%%-2.11-2.64%
6 Month39.04%%-2.02-3.04%
1 Year48.28%%7.917.43%
3 Year-6.35%%35.1236.87%

Company Info

Company Information

Managing Director : Umang Alkesh Gosalia

Non-Exec. & Independent Dir. : Ami R Shah

Non-Exec. & Independent Dir. : Nikhil S. Uchat

Company Sec. & Compli. Officer : Bhakti Rameshbhai Aghera

Registered Office: Plot No 20 Survey No 52, Tal Kotda Sangani Hadamtala,Rajkot,Gujarat-360311 Ph: 91-2827-270534/535

Email:info@parmaxpharma.com

URL:http://www.parmaxpharma.com

FAQs about Parmax Pharma Ltd

1. What's the Parmax Pharma Ltd share price today?
Parmax Pharma Ltd share price was Rs 47.76 at close on 7th Feb 2025. Parmax Pharma Ltd share price was down by 0.15% from the previous closing price of Rs 47.83. Parmax Pharma Ltd share price trend:

  • Last 1 Month: Parmax Pharma Ltd share price moved up by 11.80% on BSE
  • Last 3 Months: Parmax Pharma Ltd share price moved up by 1.62% on BSE
  • Last 12 Months: Parmax Pharma Ltd share price moved up by 48.28% on BSE
  • Last 3 Years: Parmax Pharma Ltd price moved down by 6.35% on BSE


2. How can I quickly analyse the performance of the Parmax Pharma Ltd stock?
The performance of the Parmax Pharma Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is _
  • Price to book value ratio is -22.11
  • Dividend yield of 0.00
  • The EPS (trailing 12 months) of the Parmax Pharma Ltd stock is Rs 0.00


3. What is the market cap of Parmax Pharma Ltd?
Parmax Pharma Ltd has a market capitalisation of Rs 18 crore.


4. What is Parmax Pharma Ltd's 52-week high/low share price?
The Parmax Pharma Ltd’s 52-week high share price is Rs 54.00 and 52-week low share price is Rs 24.18.


5. Is the Parmax Pharma Ltd profitable?
On a consolidated basis, Parmax Pharma Ltd reported a loss of Rs -0.22 crore on a total income of Rs 9.40 crore for the quarter ended 2024. For the year ended Sep 2024, Parmax Pharma Ltd had posted a loss of Rs -0.22 crore on a total income of Rs 9.39 crore.


6. Which are Parmax Pharma Ltd’s peers in the Health care sector?
Parmax Pharma Ltd’s top 5 peers in the Health care sector are Colinz Labs, Ishita Drugs, Norris Medicines, Parmax Pharma, Beryl Drugs, Venmax Drugs, Decipher Labs.


7. Who owns how much in Parmax Pharma Ltd?
Key changes to the Parmax Pharma Ltd shareholding are as follows:

  • Promoter holding in Parmax Pharma Ltd has gone down to 30.80 per cent as of Dec 2024 from 30.83 per cent as of Mar 2024.